<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> is prominent in <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorders</z:e>, such as <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and <z:e sem="disease" ids="C0020179" disease_type="Disease or Syndrome" abbrv="HD">Huntington's disease</z:e>, and is found in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Using a murine model of delayed cell <z:hpo ids='HP_0011420'>death</z:hpo>, we determined that cleavage of zDEVD-amino-4-<z:chebi fb="0" ids="50127">trifluoromethyl</z:chebi> <z:chebi fb="2" ids="28794">coumarin</z:chebi> (zDEVD-afc) in brain homogenate, a measure of caspase activation, increased initially 9 hours after brief (30 minutes) middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> along with caspase-3p20 immunoreactive cleavage product as determined by immunoblotting </plain></SENT>
<SENT sid="2" pm="."><plain>zDEVD-afc cleavage activity was blocked by pretreatment or posttreatment with the caspase-inhibitor N-benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethyl-<z:chebi fb="3" ids="17087">ketone</z:chebi> (zDEVD-fmk), and ischemic damage was reduced when the drug was injected up to 9 hours after reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>The protection was long lasting (21 days) </plain></SENT>
<SENT sid="4" pm="."><plain>Hence, the period before caspase activation defined the therapeutic opportunity for this neuroprotective agent after mild ischemic brain injury </plain></SENT>
<SENT sid="5" pm="."><plain>Prolonged protection after caspase inhibition plus the extended treatment window may be especially relevant to the treatment of <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorders</z:e> </plain></SENT>
</text></document>